Back to Immuno-Oncology Scientific Updates Webcast: Tumor Mutational Burden
This 1-hour, self-paced, online, CME/CMLE-accredited webcast on Tumor Mutational Burden (TMB) is designed for pathologists, laboratory professionals, and other members of the multidisciplinary cancer care team and will focus on the latest developments and scientific evidence surrounding TMB combining lecture and discussion of studies and guidelines to address the following topics:
Upon completion of this activity, you should be able to:
- Summarize ongoing investigational efforts regarding TMB and its ability to predict response to checkpoint inhibitor therapy
- Discuss the current advantages and limitations to the testing and interpretation of TMB
Ms. Lauren Ritterhouse, M.D., Ph.D.
Boston, MA 02114
The American Society for Clinical Pathology is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Credit Designation Statement
The ASCP designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only credit commensurate with the extent of their participation in the activity.
This activity also meets Continuing Certification (CC) Part II Lifelong Learning and Self-Assessment Module (SAMs CME) requirements.
ASCP designates this enduring material for a maximum of 1.0 CMLE credit. This activity meets CMP and state re-licensure requirements for laboratory personnel.
For questions regarding CME credit, please contact ASCP Customer Service at 1-800-267-2727, during normal business hours: Monday through Friday, 8 a.m. to 6 p.m. Eastern Time
Method of Participation
To complete the activity and receive credit, the participant must complete the online course. CME certificates will be provided on-line.
Funded by an independent educational grants from Bristol-Myers Squibb.